Note sharing may be a tool to improve doctor-patient communication

It’s been 20 years since patients were given the legal right to access medical notes, thanks to the Health Insurance Portability and Accountability Act (HIPAA), but wait times and processing fees often complicated the process.

Now, a pilot program that promotes easy, quick sharing of medical notes aims to improve patient engagement and education. The OpenNotes project involved 105 primary care physicians and 13,564 patients at three hospitals (Beth Israel Deaconess Medical Center in Boston, Geisinger Health System in Danville, Penn., and Harborview Medical Center in Seattle).

After a year of sharing notes, both patients and doctors supported the initiative. According to a recent report in JAMA, 99 percent of responding patients supported continued access to medical notes online, and more than 85 percent of physicians at the three locations agreed.

OpenNotes was developed by Tom Delbanco, MD, a professor of general medicine and primary care at Harvard Medical School, and Jan Walker, RN, an assistant professor of medicine at Harvard. Delbanco estimates about 100 healthcare institutions are at some stage, from planning to implementation, of sharing medical notes with patients.

Still, concerns remain about giving patients full access to medical notes. Information may be upsetting or misunderstood. Access can be limited by technology. Doctors, knowing such information will be seen, may censor themselves. The OpenNotes pilot program found 28 percent of participating physicians at Beth Israel, 9 percent at Geisinger and 11 percent at Harborview admitted to being less candid in their notes, knowing patients could read them.

“My notes are for me,” said Steven Malkin, MD, an internist. “If I knew a patient was going to read them, I would write them differently.”

Many physicians see the open sharing of notes as another way of communicating with patients.

“It is one more way they become part of decision making,” said Dawn Milliner, MD, Mayo Clinic’s chief medical information officer. “I view that as a very positive thing.”

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.